AG真人官方

GE Aerospace鈥檚 Q2-25 10-Q shows broad-based strength. Total revenue rose 21% YoY to $11.0 billion, led by Commercial Engines & Services (+30% to $8.0 billion) and Defense & Propulsion Technologies (+7% to $2.6 billion). Equipment revenue advanced 31% while services grew 21%, sustaining the high-margin aftermarket mix.

Profitability accelerated. Net income from continuing operations climbed 52% to $2.0 billion; diluted EPS reached $1.87 versus $1.20. Adjusted EPS increased 38% to $1.66. GAAP profit margin expanded to 21.7% (+580 bps), although non-GAAP operating margin slipped 10 bps to 23.0% on growth investments and inflation.

Cash & backlog solid. First-half free cash flow improved 28% to $3.55 billion, supporting $1.6 billion of Q2 share buybacks. Total RPO backlog hit $174.4 billion (+2% YTD), with Commercial backlog at $155.2 billion. Cash stood at $10.9 billion against $18.9 billion of debt; both Moody鈥檚 and S&P upgraded long-term ratings to A3/A-.

Outlook drivers. Management highlights record engine orders (e.g., Qatar Airways, IAG) and a 22% rise in internal shop-visit revenue, but flags persistent supply-chain constraints, inflation and tariff impacts. Tax rate rose to 16.2% (vs 8.6%) and Corporate adjusted costs grew $0.1 billion.

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is marketing 3-Year Autocallable Contingent Coupon Securities linked to Tesla, Inc. (TSLA). The notes pay a quarterly contingent coupon of at least 15.00% per annum (rate set on the pricing date) only when TSLA鈥檚 closing price on a valuation date is at or above the 60% coupon-barrier. Beginning after six months, the securities are subject to quarterly automatic redemption if TSLA closes at or above its initial value; investors then receive the $1,000 principal plus the coupon.

If not autocalled, the notes mature on 2-Aug-2028. At maturity holders receive $1,000 provided TSLA is at or above 60% of its initial level; otherwise payment is reduced one-for-one with TSLA鈥檚 decline, potentially to $0. Investors receive no upside participation beyond coupons. Key risks include full downside to TSLA below the 60% final barrier, loss of coupons when TSLA is below the hurdle, structural leverage to volatility, credit exposure to Citi, lack of listing, an issue-price premium over estimated value, and uncertain U.S. tax treatment.

Form 4 for HeartSciences Inc. (HSCS) discloses a new equity award to director Bruce Bent. On 07/09/2025 he received 25,000 non-derivative stock options under the 2023 Equity Incentive Plan at an exercise price of $4.37 per share, expiring on 07/09/2035. Vesting terms: 25 % vested immediately and the remaining 75 % will vest in equal quarterly tranches over the next nine months, subject to continued board service. The grant is compensation-related; no open-market purchase or sale of common shares occurred, so cash flow and immediate dilution effects are minimal. Following the grant, Bent directly holds the 25,000 options; no indirect ownership is reported.

BranchOut Food Inc. (Nasdaq: BOF) has filed a Rule 424(b)(3) resale prospectus covering up to 8,045,748 shares of common stock held or acquirable by 30+ selling stockholders. The shares consist of (i) 1,827,429 outstanding shares, (ii) 4,484,305 shares issuable upon conversion of a $3.4 million 12% senior secured convertible note held by Kaufman Kapital LLC at a fixed conversion price of $0.7582, and (iii) 1,734,014 shares issuable from multiple warrant classes with exercise prices ranging from $0.96 to $7.50.

The company itself is not issuing new shares and will receive no proceeds; selling stockholders will bear selling commissions, while BranchOut will cover registration expenses. If all convertible securities are exercised/converted, shares outstanding would rise from 10,719,769 to 16,938,088, a potential dilution of roughly 58%.

Capital structure & recent financings: Since January 2024 the company has raised cash through (1) senior secured promissory notes totaling $1.675 million (15%鈥搑ate, warrants at $1.00), (2) a private placement of $3.4 million in convertible debt to Kaufman Kapital, and (3) an insider unit offering generating $0.525 million. Kaufman Kapital also exercised 1 million $1.00 warrants for $1.0 million cash and holds an additional 500 k $1.50 warrants expiring 12/31/26. Note and warrant maturities were recently extended, and liens on 鈥渟ubstantially all assets鈥� are pari passu with earlier senior notes.

Business context: BranchOut produces plant-based dehydrated snacks and ingredients using proprietary REV dehydration technology licensed from EnWave. A new vertically integrated Peruvian facility with three large-scale REV machines commenced operations in December 2024; management expects higher operating margins in 2025 as production shifts in-house.

Key risk highlighted: Large-scale secondary sales could pressure the stock; merely registering the shares may create an overhang even if stockholders defer selling. Additional risks are incorporated by reference to prior SEC filings.

BOF last traded at $2.69 on 10 July 2025; the fixed conversion price of the note ($0.7582) and low exercise prices for many warrants are deeply in-the-money, underscoring potential dilution.